Medicare Enrolled

Dr. Lawrence Friedman, M.D.

Optician · Rockaway, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
333 MOUNT HOPE AVE, Rockaway, NJ 07866
9738956636
Registered in NPPES since 2006
NPI: 1972571990 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Friedman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Friedman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Friedman

Dr. Lawrence Friedman is an optician specialist in Rockaway, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Friedman performed 92,674 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Friedman received a total of $6,476 from 60 pharmaceutical and/or device companies across 369 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Friedman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 1% volume in NJ $6,476 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
92,674
Medicare services
Top 1% in NJ for optician
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
87,315 $0 $0
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,311 $102 $419
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
1,062 $2 $7
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
796 $9 $59
BCG treatment for bladder cancer 620 $2 $9
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
289 $12 $54
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
256 $145 $576
Leuprolide acetate (for depot suspension), 7.5 mg 231 $136 $545
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
115 $74 $294
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
80 $708 $4,185
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
80 $123 $555
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
69 $28 $119
New patient office visit, complex (60-74 min) 54 $171 $725
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
43 $79 $350
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
41 $103 $412
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
34 $108 $2,337
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
33 $6 $71
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
32 $323 $1,302
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
32 $174 $686
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
31 $27 $562
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
30 $28 $226
Complicated insertion of bladder tube 26 $126 $507
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
25 $221 $824
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $50 $184
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
21 $148 $577
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
13 $492 $2,502
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
12 $54 $236
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,476
Total received (2018-2024)
Avg $925/year across 7 years
Top 14% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
369
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,184
2023
$1,195
2022
$1,155
2021
$720
2020
$490
2019
$989
2018
$745

Payments by company (2024)

Janssen Biotech, Inc.
$213
PFIZER INC.
$112
ABBVIE INC.
$104
Sumitomo Pharma America, Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$71
AstraZeneca Pharmaceuticals LP
$66
Bayer Healthcare Pharmaceuticals Inc.
$65
Novartis Pharmaceuticals Corporation
$60
Merck Sharp & Dohme LLC
$53
IMMUNITYBIO, INC.
$52
Becton, Dickinson and Company
$47
Telix Pharmaceuticals
$43
UROGEN PHARMA, INC.
$33
180 Medical, Inc.
$27
Cycle Pharmaceuticals Inc
$22
Endo USA, Inc.
$19
Cook Medical LLC
$19
Boston Scientific Corporation
$17
Laborie Medical Technologies Corp.
$17
Endo Pharmaceuticals Inc.
$16
Blue Earth Diagnostics Limited
$15
Ferring Pharmaceuticals Inc.
$14
Top 3 companies account for 36.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,173
PFIZER INC.
$781
Janssen Biotech, Inc.
$546
PROCEPT BioRobotics Corporation
$272
Sumitomo Pharma America, Inc.
$269
Endo Pharmaceuticals Inc.
$250
ABBVIE INC.
$245
Coloplast Corp
$186
Bayer HealthCare Pharmaceuticals Inc.
$186
AstraZeneca Pharmaceuticals LP
$156
Dendreon Pharmaceuticals LLC
$135
UROVANT SCIENCES INC
$128
180 Medical, Inc.
$128
MEDIVATION FIELD SOLUTIONS LLC
$123
SUN PHARMACEUTICAL INDUSTRIES INC.
$113
Bayer Healthcare Pharmaceuticals Inc.
$105
EDAP TECHNOMED INC
$100
Merck Sharp & Dohme LLC
$100
Myovant Sciences Inc.
$91
Boston Scientific Corporation
$86
Allergan Inc.
$84
AbbVie, Inc.
$84
Hollister Incorporated
$80
Novartis Pharmaceuticals Corporation
$60
Telix Pharmaceuticals
$58
Blue Earth Diagnostics Limited
$58
IMMUNITYBIO, INC.
$52
Tolmar, Inc.
$48
Becton, Dickinson and Company
$47
Foundation Medicine, Inc.
$41
Avadel Specialty Pharmaceuticals, LLC
$40
Metuchen Pharmaceuticals
$38
AbbVie Inc.
$36
UROGEN PHARMA, INC.
$33
COLOPLAST CORP
$31
Myriad Genetic Laboratories, Inc.
$31
Progenics Pharmaceuticals, Inc.
$30
Kowa Pharmaceuticals America, Inc.
$29
TOLMAR Pharmaceuticals, Inc.
$29
Ferring Pharmaceuticals Inc.
$29
AMAG Pharmaceuticals, Inc.
$28
Novo Nordisk Inc
$27
Agiliti Surgical, Inc.
$26
Palette Life Sciences, Inc.
$24
Cycle Pharmaceuticals Inc
$22
Teleflex LLC
$19
Endo USA, Inc.
$19
Cook Medical LLC
$19
Sun Pharmaceutical Industries Inc.
$18
Medtronic USA, Inc.
$17
DENTSPLY IH Inc.
$17
NeoTract Inc.
$17
Laborie Medical Technologies Corp.
$17
Merck Sharp & Dohme Corporation
$15
TherapeuticsMD, Inc.
$15
UroGen Pharma, Inc.
$15
Clarus Therapeutics Inc.
$14
Medtronic, Inc.
$12
GENZYME CORPORATION
$12
Antares Pharma, Inc.
$12
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BOTOX · BOTOX THERAPEUTIC · CHANTIX · COOK · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · ILLUCCIX · IMVEXXY · INTERSTIM · INTRAROSA · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · Onli · Optilume BPH Drug Coated Balloon Catheter · Ozempic · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Progel Applicator Spray Tips · Prolaris · REZUM · ReTrace · Seglentis · Sonablate · Stendra · TITAN · Tiopronin · Titan · UroLift · UroLift System · VaPro · VaPro Plus Pocket · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Rockaway?
Compare opticians in the Rockaway area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
867
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
SAINT CLARE'S HOSPITAL/ DENVILLE CAMPUS
4.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Friedman is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Friedman experienced with testosterone injection?
Based on Medicare claims data, Dr. Friedman performed 87,315 testosterone injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Friedman receive payments from pharmaceutical companies?
Yes. Dr. Friedman received a total of $6,476 from 60 companies across 369 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Friedman's costs compare to other opticians in Rockaway?
Dr. Friedman's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Friedman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →